Wednesday, September 23, 2015

I'm sure you've heard of Daraprim, the drug whose price skyrocketed recently...

...After the rights to sell it under that name were bought. What I'm wondering is why the price has skyrocketed without significant government intervention. Or is the right to sell under that name enough to keep competition out? Seems implausible. Presumably, competition would decrease the price, so what's keeping entrants from the market?

link: http://ift.tt/1MJldsy